Last reviewed · How we verify

NCT05895045

Yoga for Treatment of Overactive Bladder in Pediatric Patients

Recruiting now NA Last updated 30 January 2026
What this trial tests

NA trial testing Yoga in Overactive Bladder in 40 participants. Currently enrolling.

Timeline
1 January 2026
Primary endpoint
31 December 2026
31 December 2026

Quick facts

Lead sponsorDuke University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationnon randomized
Designcrossover
Maskingsingle
Primary purposetreatment
Enrollment40
Start date1 January 2026
Primary completion31 December 2026
Estimated completion31 December 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Duke University

Who can join

Adults 8 to 18, any sex, with Overactive Bladder or Overactive Bladder Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this pilot study is to assess the impact of yoga as a treatment modality in pediatric patients age 8-18 diagnosed with idiopathic overactive bladder as measured by validated questionnaires and urinary biomarkers. The main question it aims to answer is: Does yoga help improve overactive bladder symptoms in this patient population? Participants will take part in a weekly yoga session for a total of 6 weeks with validated questionnaires and urinary samples for biomarkers to be completed at the beginning, middle and end of the study. This study will follow a cross-over study design and patients will receive standard of care while not in the active treatment arm.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Yoga

Trials testing the same drug.

Other recruiting trials for Overactive Bladder

Currently open trials in the same condition.

Other Duke University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05895045.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing